August 1, 2024Open Access

Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Radiation induced lymphopenia (RIL) deteriorate survival and diminishes the benefit of immune checkpoint inhibitors in combined treatment of lung cancer. Given the inconsistent data across various studies on the predictors of RIL, we aim to methodically elucidate these predictors and formulate a practical guide for clinicians.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Kuncman et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5dc4ab6db643587571cf8 https://doi.org/https://doi.org/10.3389/fimmu.2024.1426635

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Non–Small Cell Lung Cancer, Version 4.20242024 · 757 citations
2The study on technologies for feature selection2003 · 16 citations
3The global burden of lung cancer: current status and future trends2023 · 1,360 citations
4Dose–volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer2020 · 23 citations
5Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study2019 · 69 citations

Me gusta

Guardar

Ver artículo completo